They launched some new products namely, Mycamine inj (Micafungin) in-licensed from Astellas and Parit D capsules (Rabeprazole in combination with Domperidone) in-licensed from Eisai. Cefspan ...
Stock score of Gufic Biosciences Ltd moved up by 3 in 3 months on a 10 point scale (Source: Refinitiv). Get detailed report on Gufic Biosciences Ltd by subscribing to ETPrime.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback